基于“因加而发”理论探讨细胞焦亡在糖尿病肾病发生发展中的作用机制及证治策略
Mechanisms of Pyroptosis in the Initiation and Progression of Diabetic Kidney Disease and Related Syndrome Differentiation and Treatment Strategies: An Exploration Based on the “Yin Jia Er Fa” Theory
DOI: 10.12677/tcm.2026.1511625, PDF,   
作者: 郑婉旭, 夏世吉:黑龙江省中医药科学院,黑龙江 哈尔滨;郑艳民:开鲁县中医医院,内蒙古 通辽;迟继铭*:黑龙江省中医药科学院,黑龙江 哈尔滨;黑龙江省中医医院南岗院区,黑龙江 哈尔滨
关键词: 糖尿病肾病;因加而发;细胞焦亡;浊毒;NLRP3炎症小体;证治策略;Diabetic Kidney Disease; Yin Jia Er Fa; Pyroptosis; Turbid Toxin; NLRP3 Inflammasome; Syndrome Differentiation and Treatment Strategies
摘要: 糖尿病肾病(DKD)起病隐匿、渐进加重、遇诱暴发,与中医学“因加而发”理论所揭示的新故合邪、因加致病规律高度契合。该病病机总属本虚标实,以脾肾气阴亏虚为本,糖浊、脂浊、瘀毒内伏为宿邪;外感、劳倦、情志失调、血糖波动等新邪引动宿邪,正邪交争加剧,则蛋白尿骤增、肾功能急转直下。细胞焦亡是以NLRP3炎症小体-caspase-1-GSDMD信号轴为核心的炎性程序性死亡方式,贯穿DKD肾小球内皮细胞、足细胞、系膜细胞及肾小管上皮细胞的损伤过程,可能是“宿邪久伏”与“新邪引动”之间重要的细胞分子事件之一,细胞焦亡是中医“浊毒”病理状态在细胞层面的重要表现形式与关键驱动机制之一。基于“因加而发”理论,DKD防治宜分阶段干预:消渴期健脾益肾以绝宿邪之源,微量白蛋白尿期清热化浊以救其于芽,临床蛋白尿期化瘀泄浊、抑制焦亡以截断病势,肾功能衰竭期攻补兼施以防传变,全程调摄防新邪引动,达到“无加可发”之目的。该分期证治策略体现中医学“治未病”“既病防变”思想,与靶向焦亡的现代治疗理念相契合,可为中西医结合防治DKD提供参考。
Abstract: Diabetic kidney disease (DKD) is characterized by insidious onset, progressive aggravation, and trigger-induced flares, which is consistent with the TCM theory of “Yin Jia Er Fa” (no onset without superimposed pathogenic factors) reflecting the combination of new and pre-existing pathogens. Its pathogenesis is root deficiency with branch excess: spleen-kidney qi-yin deficiency as the root, and latent sugar turbidity, lipid turbidity, and stasis toxin as pre-existing pathogens. Newly contracted factors, such as exogenous infection, overexertion, emotional disturbance, and glucose fluctuation, may trigger these latent pathogens, as the struggle between healthy qi and pathogens intensifies, leading to sharp increases in proteinuria and rapid renal function decline. Pyroptosis, an inflammatory form of programmed cell death mediated by the NLRP3 inflammasome-caspase-1-GSDMD axis, is involved throughout the injury processes involving glomerular endothelial cells, podocytes, mesangial cells, and tubular epithelial cells. It may be a key cellular event linking latent pathogens with newly contracted triggers, and may represent an important cellular manifestation and key driver of the TCM pathological state of “turbid toxin”. Guided by the “Yin Jia Er Fa” theory, DKD management should be staged: in the Xiaoke stage, fortify the spleen and kidney to eliminate the source of latent pathogens; in the microalbuminuria stage, clear heat and resolve turbidity; in the clinical proteinuria stage, transform stasis, drain turbidity, and inhibit pyroptosis; and in the renal failure stage, combine attack and tonification. Throughout treatment, triggering factors should be avoided to achieve “Wu Jia Ke Fa” (no onset without superimposed pathogenic factors). This strategy reflects the TCM concepts of preventive treatment and preventing deterioration, aligns with modern pyroptosis-targeted therapy, and may provide a reference for integrated Chinese-Western medicine in DKD management.
文章引用:郑婉旭, 夏世吉, 郑艳民, 迟继铭. 基于“因加而发”理论探讨细胞焦亡在糖尿病肾病发生发展中的作用机制及证治策略[J]. 中医学, 2026, 15(11): 71-78. https://doi.org/10.12677/tcm.2026.1511625

参考文献

[1] 中华医学会肾脏病学分会专家组. 糖尿病肾脏疾病临床诊疗中国指南[J]. 中华肾脏病杂志, 2021, 37(3): 255-304.
[2] Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B.B., et al. (2022) IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Research and Clinical Practice, 183, Article 109119.
https://doi.org/10.1016/j.diabres.2021.109119
[3] 段佩含, 修宇飞, 李建辉, 等. 中医药调节NLRP3炎症小体治疗糖尿病肾病的研究进展[J]. 中国医药导报, 2025, 22(26): 178-181, 197.
[4] Chen, Y., Chen, R., Ji, X., Zeng, Z. and Guan, C. (2025) NLRP3 Inflammasome-Mediated Pyroptosis in Diabetic Nephropathy: Pathogenic Mechanisms and Therapeutic Targets. Journal of Inflammation Research, 18, 8399-8418.
https://doi.org/10.2147/jir.s524246
[5] 田代华, 刘更生. 灵枢经[M]. 北京: 人民卫生出版社, 2017.
[6] 周嘉培, 王小平.《黄帝内经》合邪发病观辨析[J]. 中华中医药杂志, 2021, 36(9): 5233-5236.
[7] 张介宾. 类经[M]. 北京: 中国中医药出版社, 1997.
[8] 章虚谷. 灵素节注类编[M]. 浙江: 浙江科学技术出版社, 1986.
[9] 鲍林杨.《内经》“因加而发”的发病理论研究[D]: [硕士学位论文]. 济南: 山东中医药大学, 2019.
[10] 巢元方. 诸病源候论[M]. 北京: 中国医药科技出版社, 2018.
[11] 杨霓芝, 刘旭生. 糖尿病肾病诊断、辨证分型及疗效评定标准(试行方案) [J]. 上海中医药杂志, 2007(7): 7-8.
[12] Navarro-González, J.F., Mora-Fernández, C., de Fuentes, M.M. and García-Pérez, J. (2011) Inflammatory Molecules and Pathways in the Pathogenesis of Diabetic Nephropathy. Nature Reviews Nephrology, 7, 327-340.
https://doi.org/10.1038/nrneph.2011.51
[13] Vande Walle, L. and Lamkanfi, M. (2024) Drugging the NLRP3 Inflammasome: From Signalling Mechanisms to Therapeutic Targets. Nature Reviews Drug Discovery, 23, 43-66.
https://doi.org/10.1038/s41573-023-00822-2
[14] Zheng, F., Ma, L., Li, X., Wang, Z., Gao, R., Peng, C., et al. (2022) Neutrophil Extracellular Traps Induce Glomerular Endothelial Cell Dysfunction and Pyroptosis in Diabetic Kidney Disease. Diabetes, 71, 2739-2750.
https://doi.org/10.2337/db22-0153
[15] Zhang, C., Gong, Y., Li, N., Liu, X., Zhang, Y., Ye, F., et al. (2021) Long Noncoding RNA Kcnq1ot1 Promotes sC5b-9-Induced Podocyte Pyroptosis by Inhibiting miR-486a-3p and Upregulating NLRP3. American Journal of Physiology-Cell Physiology, 320, C355-C364.
https://doi.org/10.1152/ajpcell.00403.2020
[16] 徐大椿, 万芳. 医学源流论[M]. 北京: 人民卫生出版社, 2023.
[17] 张介宾, 李继明. 景岳全书[M]. 北京: 人民卫生出版社, 2023.
[18] Shahzad, K., Bock, F., Dong, W., Wang, H., Kopf, S., Kohli, S., et al. (2015) NLRP3-Inflammasome Activation in Non-Myeloid-Derived Cells Aggravates Diabetic Nephropathy. Kidney International, 87, 74-84.
https://doi.org/10.1038/ki.2014.271
[19] Zhang, M., Liu, W., Liu, Y., Zhang, Z., Hu, Y., Sun, D., et al. (2023) Astragaloside IV Inhibited Podocyte Pyroptosis in Diabetic Kidney Disease by Regulating SIRT6/HIF-1α Axis. DNA and Cell Biology, 42, 594-607.
https://doi.org/10.1089/dna.2023.0102
[20] Han, W., Ma, Q., Liu, Y., Wu, W., Tu, Y., Huang, L., et al. (2019) Huangkui Capsule Alleviates Renal Tubular Epithelial-Mesenchymal Transition in Diabetic Nephropathy via Inhibiting NLRP3 Inflammasome Activation and TLR4/NF-κB Signaling. Phytomedicine, 57, 203-214.
https://doi.org/10.1016/j.phymed.2018.12.021
[21] Li, W., He, W., Xia, P., Sun, W., Shi, M., Zhou, Y., et al. (2019) Total Extracts of Abelmoschus Manihot L. Attenuates Adriamycin-Induced Renal Tubule Injury via Suppression of Ros-Erk1/2-Mediated NLRP3 Inflammasome Activation. Frontiers in Pharmacology, 10, Article No. 567.
https://doi.org/10.3389/fphar.2019.00567
[22] Zhang, Q., Liu, X., Sullivan, M.A., Shi, C. and Deng, B. (2021) Protective Effect of Yi Shen Pai Du Formula against Diabetic Kidney Injury via Inhibition of Oxidative Stress, Inflammation, and Epithelial‐to‐Mesenchymal Transition in db/db Mice. Oxidative Medicine and Cellular Longevity, 2021, Article ID: 7958021.
https://doi.org/10.1155/2021/7958021
[23] Yi, Z., Peng, Y., Hui, B., Liu, Z., Lin, Q., Zhao, D., et al. (2023) Zuogui-Jiangtang-yishen Decoction Prevents Diabetic Kidney Disease: Intervene Pyroptosis Induced by Trimethylamine N-Oxide through the mROS-NLRP3 Axis. Phytomedicine, 114, Article 154775.
https://doi.org/10.1016/j.phymed.2023.154775
[24] Li, N., Zhao, T., Cao, Y., Zhang, H., Peng, L., Wang, Y., et al. (2021) Tangshen Formula Attenuates Diabetic Kidney Injury by Imparting Anti-Pyroptotic Effects via the TXNIP-NLRP3-GSDMD Axis. Frontiers in Pharmacology, 11, Article ID: 623489.
https://doi.org/10.3389/fphar.2020.623489
[25] Lv, C., Cheng, T., Zhang, B., Sun, K. and Lu, K. (2023) Triptolide Protects against Podocyte Injury in Diabetic Nephropathy by Activating the NRF2/Ho-1 Pathway and Inhibiting the NLRP3 Inflammasome Pathway. Renal Failure, 45, Article 2165103.
https://doi.org/10.1080/0886022x.2023.2165103
[26] Ma, Z., Zhu, L., Wang, S., Guo, X., Sun, B., Wang, Q., et al. (2022) Berberine Protects Diabetic Nephropathy by Suppressing Epithelial-to-Mesenchymal Transition Involving the Inactivation of the NLRP3 Inflammasome. Renal Failure, 44, 923-932.
https://doi.org/10.1080/0886022x.2022.2079525
[27] Wang, T., Gao, Y., Yue, R., Wang, X., Shi, Y., Xu, J., et al. (2020) Ginsenoside Rg1 Alleviates Podocyte Injury Induced by Hyperlipidemia via Targeting the mTOR/NF‐κB/NLRP3 Axis. Evidence-Based Complementary and Alternative Medicine, 2020, Article ID: 2735714.
https://doi.org/10.1155/2020/2735714
[28] Yu, Q., Zhang, M., Qian, L., Wen, D. and Wu, G. (2019) Luteolin Attenuates High Glucose-Induced Podocyte Injury via Suppressing NLRP3 Inflammasome Pathway. Life Sciences, 225, 1-7.
https://doi.org/10.1016/j.lfs.2019.03.073
[29] Wu, Q., Guan, Y., Zhang, K., Li, L. and Zhou, Y. (2023) Tanshinone IIA Mediates Protection from Diabetes Kidney Disease by Inhibiting Oxidative Stress Induced Pyroptosis. Journal of Ethnopharmacology, 316, Article 116667.
https://doi.org/10.1016/j.jep.2023.116667
[30] Li, G., Liu, C., Yang, L., Feng, L., Zhang, S., An, J., et al. (2023) Syringaresinol Protects against Diabetic Nephropathy by Inhibiting Pyroptosis via NRF2-Mediated Antioxidant Pathway. Cell Biology and Toxicology, 39, 621-639.
https://doi.org/10.1007/s10565-023-09790-0
[31] 赵沛东, 郭闫闫, 任相阁, 等. 雷公藤及其活性成分治疗糖尿病肾病的作用机制研究进展[J]. 中国实验方剂学杂志, 2026, 32(7): 352-362.
[32] Jin, J. and Zhang, M. (2024) Exploring the Role of NLRP3 Inflammasome in Diabetic Nephropathy and the Advancements in Herbal Therapeutics. Frontiers in Endocrinology, 15, Article ID: 1397301.
https://doi.org/10.3389/fendo.2024.1397301